Page last updated: 2024-09-03

imatinib mesylate and Interstitial Cell Tumor

imatinib mesylate has been researched along with Interstitial Cell Tumor in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arizzi, M; Basciani, S; Brama, M; De Luca, G; Dolci, S; Gnessi, L; Mariani, S; Pisano, C; Spera, G; Vesci, L	1
Beuthien-Baumann, B; Dittert, DD; Froehner, M; Schuler, U; Wirth, MP	1

Other Studies

2 other study(ies) available for imatinib mesylate and Interstitial Cell Tumor

Article	Year
Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity. Cancer research, 2005, Mar-01, Volume: 65, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Proliferation; Humans; Imatinib Mesylate; In Vitro Techniques; Leydig Cell Tumor; Ligands; Male; Mice; Mice, Inbred C57BL; Mutation; Phosphorylation; Piperazines; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Proto-Oncogene Proteins c-sis; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; RNA, Messenger; RNA, Neoplasm	2005
Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumor. Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:5 Topics: Aged; Antineoplastic Agents; Benzamides; Disease Progression; Enzyme Inhibitors; Humans; Imatinib Mesylate; Leydig Cell Tumor; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Testicular Neoplasms; Treatment Failure	2006

Article

Year

Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.

Cancer research, 2005, Mar-01, Volume: 65, Issue:5

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Proliferation; Humans; Imatinib Mesylate; In Vitro Techniques; Leydig Cell Tumor; Ligands; Male; Mice; Mice, Inbred C57BL; Mutation; Phosphorylation; Piperazines; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Proto-Oncogene Proteins c-sis; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; RNA, Messenger; RNA, Neoplasm

2005

Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumor.

Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:5

Topics: Aged; Antineoplastic Agents; Benzamides; Disease Progression; Enzyme Inhibitors; Humans; Imatinib Mesylate; Leydig Cell Tumor; Male; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Testicular Neoplasms; Treatment Failure

2006